PARMA, Italy, May 7 /PRNewswire/ -- The Parma Group has reacquired the marketing rights to its own drug Curosurf and is laying the groundwork to acquire control of the American pharmaceutical company Cornerstone; it will be setting up its twenty-third associated company in the world's largest pharmaceuticals market.